Nanfang Hospital of Southern Medical University — Guangzhou, Guangdong

Which of these are you?

🧭 Patient, caregiver or referring clinician

This page counts public registry records — it is not a list of trials you can join.

Studies recruiting near Guangzhou →

Never medical advice — always discuss trial participation with your own doctor first.

🏢 I work at this facility, a sponsor or a CRO

Verify and correct how this facility appears in public registry records — free — and open the full registry-entry list below.

Verify this profile →

Public research footprint of Nanfang Hospital of Southern Medical University, compiled from the ClinicalTrials.gov public registry.

224

Registered studies

81

Active

41

Recruiting now

90

Completed

12

Stopped or withdrawn

Most-studied conditions

Glypican-3 (GPC3)-Positive Squamous Non-small Cell Lung Cancer · Carcinoma, Non-Small-Cell Lung (NSCLC) · MSI-H/dMMR Solid Tumors · Subacute Cutaneous Lupus Erythematosus

Recently updated registry entries

NCT07218341 — A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic… (Recruiting)
NCT07729839 — Safety, Tolerability, and Pharmacokinetic Evaluation of ADB116 for Injection (Recruiting)
NCT06097260 — Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for… (Terminated)

7 more recent registry entries at this facility

Research staff — enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.